Found: 24
Select item for more details and to access through your institution.
Effect of gentamicin on pharmacokinetics of lysozyme in rats: interaction between megalin substrates in the kidney.
- Published in:
- Journal of Pharmacy & Pharmacology, 2002, v. 54, n. 11, p. 1491, doi. 10.1211/00223570272
- By:
- Publication type:
- Article
739. Prediction of Cefiderocol Pharmacokinetics and Probability of Target Attainment in Pediatric Subjects for Proposing Dose Regimens.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S330, doi. 10.1093/ofid/ofz360.807
- By:
- Publication type:
- Article
Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model‐based approach.
- Published in:
- Pharmacology Research & Perspectives, 2024, v. 12, n. 5, p. 1, doi. 10.1002/prp2.70001
- By:
- Publication type:
- Article
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 597, doi. 10.1007/s40121-024-00946-x
- By:
- Publication type:
- Article
Pharmacokinetic–pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice.
- Published in:
- Biopharmaceutics & Drug Disposition, 2021, v. 42, n. 4, p. 178, doi. 10.1002/bdd.2271
- By:
- Publication type:
- Article
Is platelet monitoring during 7‐day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open‐label study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 10, p. 1141, doi. 10.1111/hepr.13544
- By:
- Publication type:
- Article
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 12, p. 1659, doi. 10.1007/s00228-020-02960-7
- By:
- Publication type:
- Article
Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 931, doi. 10.1007/s00228-018-2458-9
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S552, doi. 10.1093/cid/ciz828
- By:
- Publication type:
- Article
Quantitative systems pharmacology model of thrombopoiesis and platelet life‐cycle, and its application to thrombocytopenia based on chronic liver disease.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 5, p. 489, doi. 10.1002/psp4.12623
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of covariate effects using variance-based global sensitivity analysis in pharmacometrics.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2021, v. 48, n. 6, p. 851, doi. 10.1007/s10928-021-09775-8
- By:
- Publication type:
- Article
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 7, p. 1069, doi. 10.1007/s40262-022-01146-x
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 4, p. 539, doi. 10.1007/s40262-021-01086-y
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 5, p. 670, doi. 10.1002/jcph.1986
- By:
- Publication type:
- Article
Metabolism, Excretion, and Pharmacokinetics of [<sup>14</sup>C]‐Cefiderocol (S‐649266), a Siderophore Cephalosporin, in Healthy Subjects Following Intravenous Administration.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 7, p. 958, doi. 10.1002/jcph.1386
- By:
- Publication type:
- Article
Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 5, p. 584, doi. 10.1002/jcph.841
- By:
- Publication type:
- Article
Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child-Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2021, v. 76, n. 11, p. 3069, doi. 10.1093/jac/dkab343
- By:
- Publication type:
- Article
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects.
- Published in:
- 2019
- By:
- Publication type:
- journal article